[{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 20 insertion","proteinChange":"762_823ins","cancerType":"Non-Small Cell Lung Cancer","level":"R1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"23371856, 24065731, 19536777, 24353160, 21764376, 18676761, 24893891, 23328547, 1867676, 15897572, 17686547","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"T790M","proteinChange":"T790M","cancerType":"Non-Small Cell Lung Cancer","level":"R1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"24478319, 26051236, 23816963","abstracts":"Yang et al. Abstract# O03.05, IASLC 2013 http://library.iaslc.org/search-speaker?search_speaker=17991"},{"isoform":"ENST00000256078","refSeq":"NM_033360.2","entrezGeneId":3845,"gene":"KRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Colorectal Cancer","level":"R1","drugs":"Panitumumab, Cetuximab","pmids":"21228335, 20619739, 18316791, 20921465, 24024839","abstracts":""},{"isoform":"ENST00000369535","refSeq":"NM_002524.4","entrezGeneId":4893,"gene":"NRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Colorectal Cancer","level":"R1","drugs":"Panitumumab, Cetuximab","pmids":"20619739, 24024844, 25110411, 24024839","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"D842V","proteinChange":"D842V","cancerType":"Gastrointestinal Stromal Tumor","level":"R1","drugs":"Imatinib","pmids":"25905001, 17087936, 12949711, 24963404, 22718859, 15928335, 18955458, 23752188, 22745105, 15685537, 18794084","abstracts":""},{"isoform":"ENST00000318560","refSeq":"NM_005157.4","entrezGeneId":25,"gene":"ABL1","variant":"BCR-ABL1 Fusion","proteinChange":"BCR-ABL1 Fusion","cancerType":"B-Lymphoblastic Leukemia/Lymphoma","level":"1","drugs":"Dasatinib, Imatinib","pmids":"17496201, 11287973, 24441288, 20131302, 21931113, 12200353","abstracts":""},{"isoform":"ENST00000318560","refSeq":"NM_005157.4","entrezGeneId":25,"gene":"ABL1","variant":"BCR-ABL1 Fusion","proteinChange":"BCR-ABL1 Fusion","cancerType":"Chronic Myelogenous Leukemia","level":"1","drugs":"Nilotinib, Dasatinib, Imatinib","pmids":"28095277, 28218239, 27217448, 11287973, 12637609, 20525993, 20525995, 11287972, 23502220","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"Fusions","proteinChange":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Crizotinib, Brigatinib, Alectinib, Ceritinib","pmids":"28586279, 29596029, 29668860, 28475456, 28126333, 30280657, 23724913","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","proteinChange":"V600E","cancerType":"Anaplastic Thyroid Cancer","level":"1","drugs":"Dabrafenib + Trametinib","pmids":"29072975","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600","proteinChange":"V600","cancerType":"Erdheim-Chester Disease","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","proteinChange":"V600E","cancerType":"Melanoma","level":"1","drugs":"Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib, Encorafenib + Binimetinib","pmids":"29573941, 22735384, 28961848, 25265494, 25287827, 25399551, 22608338, 23051966, 28891408, 27480103, 22663011, 25265492, 24508103, 29361468, 28991513, 23020132","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600K","proteinChange":"V600K","cancerType":"Melanoma","level":"1","drugs":"Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib, Encorafenib + Binimetinib","pmids":"29573941, 28891408, 27480103, 22663011, 25265492, 25265494, 25287827, 29361468, 28991513, 23020132, 25399551","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","proteinChange":"V600E","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Dabrafenib + Trametinib","pmids":"27283860, 28919011","abstracts":""},{"isoform":"ENST00000357654","refSeq":"NM_007294.3","entrezGeneId":672,"gene":"BRCA1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"1","drugs":"Rucaparib, Niraparib","pmids":"27717299, 28882436, 28916367","abstracts":""},{"isoform":"ENST00000380152","refSeq":"NM_000059.3","entrezGeneId":675,"gene":"BRCA2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"1","drugs":"Rucaparib, Niraparib","pmids":"27717299, 28882436, 28916367","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"A750P","proteinChange":"A750P","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"28336552, 19625781, 25179728, 15737014","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"A763_Y764insFQEA","proteinChange":"A763_Y764insFQEA","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"23371856, 24353160, 23969006","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"E709K","proteinChange":"E709K","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"28336552, 23566546, 18000506, 25179728, 25130612, 23749122, 15710947","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"E709_T710delinsD","proteinChange":"E709_T710delinsD","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 28336552, 26206867","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 19 deletion","proteinChange":"729_761del","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Osimertinib, Dacomitinib, Gefitinib","pmids":"28958502, 23816960, 20022809, 21670455, 29151359, 22452895, 25589191, 22285168, 29864379, 19692680, 27987585, 22370314, 20573926","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 19 deletion/insertion","proteinChange":"729_761indel","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Osimertinib, Dacomitinib, Gefitinib","pmids":"28958502, 23816960, 20022809, 21670455, 29151359, 22452895, 25589191, 22285168, 29864379, 19692680, 27987585, 22370314, 20573926","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 19 insertion","proteinChange":"729_761ins","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"28336552, 22190593","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"G719","proteinChange":"G719","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 28336552, 15118073, 26051236, 21670455, 16011858, 24285021, 20573926","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Kinase Domain Duplication","proteinChange":"Kinase Domain Duplication","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"28336552, 26286086","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L747P","proteinChange":"L747P","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"28336552, 22190593","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L833V","proteinChange":"L833V","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21949883, 23912954, 25130612, 20808254, 21422421","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L858R","proteinChange":"L858R","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Osimertinib, Dacomitinib, Gefitinib","pmids":"28958502, 23816960, 20022809, 21670455, 29151359, 22452895, 25589191, 22285168, 29864379, 19692680, 27987585, 22370314, 20573926","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L861","proteinChange":"L861","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 28336552, 26051236","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"M277E","proteinChange":"M277E","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"28979142","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"S768I","proteinChange":"S768I","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"17285735, 28336552, 25521405, 26051236","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"T790M","proteinChange":"T790M","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Osimertinib","pmids":"25923549, 27751847, 29151359","abstracts":""},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Amplification","proteinChange":"Amplification","cancerType":"Breast Cancer","level":"1","drugs":"Lapatinib + Trastuzumab, Pertuzumab + Trastuzumab, Ado-Trastuzumab Emtansine, Lapatinib, Neratinib, Trastuzumab","pmids":"22149875, 19060928, 16236738, 19786658, 22153890, 26874901, 29320312, 22257673, 29146401, 23020162, 16091755, 23602601, 17192538","abstracts":""},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Amplification","proteinChange":"Amplification","cancerType":"Esophagogastric Cancer","level":"1","drugs":"Trastuzumab","pmids":"20728210","abstracts":""},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Ivosidenib","pmids":"23393090, 23558169, 29860938","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R140Q","proteinChange":"R140Q","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"28588020","abstracts":""},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R172","proteinChange":"R172","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"28588020","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","proteinChange":"C788_N828mut","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib","pmids":"23177515","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib, Sunitinib, Imatinib","pmids":"28196207, 18955451, 18235122, 12181401, 17046465, 23177515","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"T670I","proteinChange":"T670I","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib, Sunitinib","pmids":"17046465, 17699867, 23177515","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"V654A","proteinChange":"V654A","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib, Sunitinib","pmids":"17046465, 23177515","abstracts":""},{"isoform":"ENST00000256078","refSeq":"NM_033360.2","entrezGeneId":3845,"gene":"KRAS","variant":"Wildtype","proteinChange":"Wildtype","cancerType":"Colorectal Cancer","level":"1","drugs":"Regorafenib, Panitumumab, Cetuximab","pmids":"20921462, 24739896, 20921465, 19339720, 15677699, 23177514","abstracts":""},{"isoform":null,"refSeq":null,"entrezGeneId":-2,"gene":"Other Biomarkers","variant":"Microsatellite Instability-High","proteinChange":"MSI-H","cancerType":"All Solid Tumors","level":"1","drugs":"Pembrolizumab","pmids":"28596308, 26028255","abstracts":""},{"isoform":null,"refSeq":null,"entrezGeneId":-2,"gene":"Other Biomarkers","variant":"Microsatellite Instability-High","proteinChange":"MSI-H","cancerType":"Colorectal Cancer","level":"1","drugs":"Nivolumab","pmids":"28734759","abstracts":"Andre et al. Abstract# 553, GCS 2018 https://meetinglibrary.asco.org/record/155742/abstract"},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"FIP1L1-PDGFRA Fusion","proteinChange":"FIP1L1-PDGFRA Fusion","cancerType":"Chronic Eosinophilic Leukemia, NOS","level":"1","drugs":"Imatinib","pmids":"18950453","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"Fusions","proteinChange":"Fusions","cancerType":"Myelodysplastic/Myeloproliferative Neoplasms","level":"1","drugs":"Imatinib","pmids":"12944919, 17555450, 12660384, 16498388, 14504092, 16845659, 18950453, 15034867","abstracts":""},{"isoform":"ENST00000261799","refSeq":"NM_002609.3","entrezGeneId":5159,"gene":"PDGFRB","variant":"Fusions","proteinChange":"Fusions","cancerType":"Dermatofibrosarcoma Protuberans","level":"1","drugs":"Imatinib","pmids":"20439456, 21128251, 15503291, 15746584, 18451237, 15681532, 19620561","abstracts":""},{"isoform":"ENST00000261799","refSeq":"NM_002609.3","entrezGeneId":5159,"gene":"PDGFRB","variant":"Fusions","proteinChange":"Fusions","cancerType":"Myelodysplastic/Myeloproliferative Neoplasms","level":"1","drugs":"Imatinib","pmids":"16960151, 12676775, 12181402, 14504092, 18950453, 24687085, 22897847, 26355392, 1516603","abstracts":""},{"isoform":"ENST00000368508","refSeq":"NM_002944.2","entrezGeneId":6098,"gene":"ROS1","variant":"Fusions","proteinChange":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Crizotinib","pmids":"25264305, 29596029","abstracts":""},{"isoform":"ENST00000298552","refSeq":"NM_000368.4","entrezGeneId":7248,"gene":"TSC1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"CNS Cancer","level":"1","drugs":"Everolimus","pmids":"23158522","abstracts":""},{"isoform":"ENST00000219476","refSeq":"NM_000548.3","entrezGeneId":7249,"gene":"TSC2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"CNS Cancer","level":"1","drugs":"Everolimus","pmids":"23158522","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"Fusions","proteinChange":"Fusions","cancerType":"Inflammatory Myofibroblastic Tumor","level":"2A","drugs":"Crizotinib, Ceritinib","pmids":"26020125, 24670165, 20979472, 23598171","abstracts":""},{"isoform":"ENST00000357654","refSeq":"NM_007294.3","entrezGeneId":672,"gene":"BRCA1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"2A","drugs":"Olaparib","pmids":"25366685, 24882434","abstracts":""},{"isoform":"ENST00000380152","refSeq":"NM_000059.3","entrezGeneId":675,"gene":"BRCA2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"2A","drugs":"Olaparib","pmids":"25366685, 24882434","abstracts":""},{"isoform":"ENST00000257904","refSeq":"NM_000075.3","entrezGeneId":1019,"gene":"CDK4","variant":"Amplification","proteinChange":"Amplification","cancerType":"Dedifferentiated Liposarcoma","level":"2A","drugs":"Abemaciclib, Palbociclib","pmids":"23569312, 27124835","abstracts":""},{"isoform":"ENST00000257904","refSeq":"NM_000075.3","entrezGeneId":1019,"gene":"CDK4","variant":"Amplification","proteinChange":"Amplification","cancerType":"Well-Differentiated Liposarcoma","level":"2A","drugs":"Abemaciclib, Palbociclib","pmids":"23569312, 27124835","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","proteinChange":"C788_N828mut","cancerType":"Gastrointestinal Stromal Tumor","level":"2A","drugs":"Sorafenib","pmids":"23140824, 22270258","abstracts":"Kindler et al. Abstract# 10009, ASCO 2011 http://meetinglibrary.asco.org/content/80567-102"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816","proteinChange":"D816","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","proteinChange":"C788_N828mut","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"T670I","proteinChange":"T670I","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"V654A","proteinChange":"V654A","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 21642685","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816","proteinChange":"D816","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","proteinChange":"C788_N828mut","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"T670I","proteinChange":"T670I","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"V654A","proteinChange":"V654A","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"14991904, 25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Amplification","proteinChange":"Amplification","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010H","proteinChange":"D1010H","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010N","proteinChange":"D1010N","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010Y","proteinChange":"D1010Y","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Exon 14 splice mutation","proteinChange":"963_1028splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003C","proteinChange":"Y1003C","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003F","proteinChange":"Y1003F","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003N","proteinChange":"Y1003N","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265, 25971939, 26729443","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Amplification","proteinChange":"Amplification","cancerType":"Renal Cell Carcinoma","level":"2A","drugs":"Cabozantinib","pmids":"27279544, 27462141","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"D842V","proteinChange":"D842V","cancerType":"Gastrointestinal Stromal Tumor","level":"2A","drugs":"Dasatinib","pmids":"","abstracts":"Trent et al. Abstract# 10006, ASCO 2011 http://meetinglibrary.asco.org/content/79120-102"},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Gastrointestinal Stromal Tumor","level":"2A","drugs":"Imatinib","pmids":"22718859","abstracts":""},{"isoform":"ENST00000355710","refSeq":"NM_020975.4","entrezGeneId":5979,"gene":"RET","variant":"Fusions","proteinChange":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Cabozantinib, Vandetanib","pmids":"27803005, 28447912, 27825636, 23533264","abstracts":""},{"isoform":"ENST00000298552","refSeq":"NM_000368.4","entrezGeneId":7248,"gene":"TSC1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Renal Cell Carcinoma","level":"2A","drugs":"Everolimus","pmids":"26831717","abstracts":""},{"isoform":"ENST00000219476","refSeq":"NM_000548.3","entrezGeneId":7249,"gene":"TSC2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Renal Cell Carcinoma","level":"2A","drugs":"Everolimus","pmids":"26831717","abstracts":""},{"isoform":"ENST00000349310","refSeq":"NM_001014431.1","entrezGeneId":207,"gene":"AKT1","variant":"E17K","proteinChange":"E17K","cancerType":"Breast Cancer","level":"3A","drugs":"AZD5363","pmids":"22294718, 23394218, 28489509, 26351323","abstracts":""},{"isoform":"ENST00000349310","refSeq":"NM_001014431.1","entrezGeneId":207,"gene":"AKT1","variant":"E17K","proteinChange":"E17K","cancerType":"Endometrial Cancer","level":"3A","drugs":"AZD5363","pmids":"22294718, 23394218, 28489509, 26351323","abstracts":""},{"isoform":"ENST00000349310","refSeq":"NM_001014431.1","entrezGeneId":207,"gene":"AKT1","variant":"E17K","proteinChange":"E17K","cancerType":"Ovarian Cancer","level":"3A","drugs":"AZD5363","pmids":"22294718, 23394218, 28489509, 26351323","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"G1202R","proteinChange":"G1202R","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Lorlatinib","pmids":"29650534, 29074098","abstracts":"Besse et al. Abstract #9032, ASCO 2018 https://media4.asco.org/214/12951/160995/160995_poster_big_1.jpg"},{"isoform":"ENST00000377045","refSeq":"NM_001654.4","entrezGeneId":369,"gene":"ARAF","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Histiocytosis","level":"3A","drugs":"Sorafenib","pmids":"24569458, 26566875","abstracts":""},{"isoform":"ENST00000377045","refSeq":"NM_001654.4","entrezGeneId":369,"gene":"ARAF","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Sorafenib","pmids":"24569458","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600","proteinChange":"V600","cancerType":"Colorectal Cancer","level":"3A","drugs":"Panitumumab + Dabrafenib + Trametinib","pmids":"19884556, 29431699, 20619739, 25589621, 19001320, 22448344","abstracts":"Bendell, J et al. Abstract#3515, J Clin Oncol, 32, 2014 http://ascopubs.org/doi/abs/10.1200/jco.2014.32.15_suppl.3515; Kopetz, S. et al. Abstract#3534. J. Clin. Oncol. 28. 2010 http://ascopubs.org/doi/abs/10.1200/jco.2010.28.15_suppl.3534"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"Fusions","proteinChange":"Fusions","cancerType":"Melanoma","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"26314551, 23890088, 24345920, 26072686","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"K601","proteinChange":"K601","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 28344857, 24933606, 23248257","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597","proteinChange":"L597","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 24933606","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"Fusions","proteinChange":"Fusions","cancerType":"Ovarian Cancer","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"23890088, 26324360, 24345920","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 20 insertion","proteinChange":"762_823ins","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Poziotinib","pmids":"27188206, 29686424","abstracts":"Heymach et al. Abstract# OA02.06, WCLC 2018 https://wclc2018.iaslc.org/wp-content/uploads/2018/09/WCLC2018-Abstract-Book_vF-LR-REV-SEPT-25-2018.pdf"},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Breast Cancer","level":"3A","drugs":"Neratinib","pmids":"23220880","abstracts":"Hyman et al. Abstract# CT001, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/CT001"},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Neratinib","pmids":"23220880","abstracts":"Hyman et al. Abstract# CT001, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/CT001"},{"isoform":"ENST00000391945","refSeq":"NM_000400.3","entrezGeneId":2068,"gene":"ERCC2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Bladder Cancer","level":"3A","drugs":"Cisplatin","pmids":"12208738, 25096233, 27310333","abstracts":""},{"isoform":"ENST00000206249","refSeq":"NM_001122740.1","entrezGeneId":2099,"gene":"ESR1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Breast Cancer","level":"3A","drugs":"AZD9496, Fulvestrant","pmids":"27986707, 27269946","abstracts":""},{"isoform":"ENST00000425967","refSeq":"NM_001174067.1","entrezGeneId":2260,"gene":"FGFR1","variant":"Amplification","proteinChange":"Amplification","cancerType":"Lung Squamous Cell Carcinoma","level":"3A","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"27870574, 23082000","abstracts":"Voss, MH et al. Abstract# 2500, ASCO 2017 http://meetinglibrary.asco.org/record/144575/abstract"},{"isoform":"ENST00000358487","refSeq":"NM_000141.4","entrezGeneId":2263,"gene":"FGFR2","variant":"Fusions","proteinChange":"Fusions","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"26324363, 27870574, 24122810","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000358487","refSeq":"NM_000141.4","entrezGeneId":2263,"gene":"FGFR2","variant":"Fusions","proteinChange":"Fusions","cancerType":"Cholangiocarcinoma","level":"3A","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"29182496, 24122810","abstracts":"Cleary et al. Abstract# 447, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155948/abstract"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"Fusions","proteinChange":"Fusions","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"29848605, 26324363, 22837387","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"G370C","proteinChange":"G370C","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"G380R","proteinChange":"G380R","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650","proteinChange":"K650","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"R248C","proteinChange":"R248C","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"S249C","proteinChange":"S249C","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"S371C","proteinChange":"S371C","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"Y373C","proteinChange":"Y373C","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"21119661, 29848605, 26324363, 27870574","abstracts":"Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract"},{"isoform":"ENST00000241453","refSeq":"NM_004119.2","entrezGeneId":2322,"gene":"FLT3","variant":"Internal tandem duplication","proteinChange":"Internal tandem duplication","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Sorafenib","pmids":"18230792, 22368270","abstracts":""},{"isoform":"ENST00000311189","refSeq":"NM_001130442.1","entrezGeneId":3265,"gene":"HRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Head and Neck Squamous Cell Carcinoma","level":"3A","drugs":"Tipifarnib","pmids":"12497061, 24240680","abstracts":"Ho et al. Abstract# TPS2618, JCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.TPS2618"},{"isoform":"ENST00000381652","refSeq":"NM_004972.3","entrezGeneId":3717,"gene":"JAK2","variant":"PCM1-JAK2 Fusion","proteinChange":"PCM1-JAK2 Fusion","cancerType":"Chronic Eosinophilic Leukemia, NOS","level":"3A","drugs":"Ruxolitinib","pmids":"22899477, 25207766, 26202607, 23630205, 22875628, 25515960, 23400675, 25260694","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816","proteinChange":"D816","cancerType":"Mastocytosis","level":"3A","drugs":"Avapritinib","pmids":"29233825","abstracts":"DeAngelo et al. Blood 2017 130:2, ASH 2017 http://www.bloodjournal.org/content/130/Suppl_1/2; Drummond et al. Blood 128:477, ASH 2016 http://www.bloodjournal.org/content/128/22/477"},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Histiocytosis","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Low-Grade Serous Ovarian Cancer","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Melanoma","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000462284","refSeq":"NM_002392.5","entrezGeneId":4193,"gene":"MDM2","variant":"Amplification","proteinChange":"Amplification","cancerType":"Liposarcoma","level":"3A","drugs":"DS-3032b, RG7112","pmids":"23400593, 23084521","abstracts":"Gounder et al. Abstract# 2581, ASCO 2016 http://meetinglibrary.asco.org/content/166204-176; Abstract: Bauer T et al. Abstract# B27, AACR 2015 http://mct.aacrjournals.org/content/14/12_Supplement_2/B27"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010H","proteinChange":"D1010H","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010N","proteinChange":"D1010N","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010Y","proteinChange":"D1010Y","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Exon 14 splice mutation","proteinChange":"963_1028splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003C","proteinChange":"Y1003C","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003F","proteinChange":"Y1003F","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003N","proteinChange":"Y1003N","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"E2014K","proteinChange":"E2014K","cancerType":"Bladder Cancer","level":"3A","drugs":"Everolimus","pmids":"24625776, 23551593","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"E2419K","proteinChange":"E2419K","cancerType":"Bladder Cancer","level":"3A","drugs":"Everolimus","pmids":"24625776, 23551593","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"L1460P","proteinChange":"L1460P","cancerType":"Renal Cell Carcinoma","level":"3A","drugs":"Temsirolimus","pmids":"26831717","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"L2209V","proteinChange":"L2209V","cancerType":"Renal Cell Carcinoma","level":"3A","drugs":"Temsirolimus","pmids":"26831717","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"L2427Q","proteinChange":"L2427Q","cancerType":"Renal Cell Carcinoma","level":"3A","drugs":"Temsirolimus","pmids":"26831717","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"Q2223K","proteinChange":"Q2223K","cancerType":"Renal Cell Carcinoma","level":"3A","drugs":"Everolimus","pmids":"24622468","abstracts":""},{"isoform":"ENST00000369535","refSeq":"NM_002524.4","entrezGeneId":4893,"gene":"NRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Melanoma","level":"3A","drugs":"Binimetinib, Binimetinib + Ribociclib","pmids":"16273091, 28284557, 22983396","abstracts":"Schuler et al. Abstract #9519, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.9519"},{"isoform":"ENST00000369535","refSeq":"NM_002524.4","entrezGeneId":4893,"gene":"NRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Thyroid Cancer","level":"3A","drugs":"Selumetinib + Radioiodine Uptake Therapy","pmids":"22105174, 23406027","abstracts":""},{"isoform":"ENST00000524377","refSeq":"NM_002529.3","entrezGeneId":4914,"gene":"NTRK1","variant":"Fusions","proteinChange":"Fusions","cancerType":"All Solid Tumors","level":"3A","drugs":"Larotrectinib, Entrectinib","pmids":"26216294, 29466156, 28183697","abstracts":"Pishvaian et al. Abstract# 521, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155954/abstract"},{"isoform":"ENST00000277120","refSeq":"NM_006180.3","entrezGeneId":4915,"gene":"NTRK2","variant":"Fusions","proteinChange":"Fusions","cancerType":"All Solid Tumors","level":"3A","drugs":"Larotrectinib, Entrectinib","pmids":"26216294, 29466156, 28183697","abstracts":"Pishvaian et al. Abstract# 521, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155954/abstract"},{"isoform":"ENST00000360948","refSeq":"NM_001012338.2","entrezGeneId":4916,"gene":"NTRK3","variant":"Fusions","proteinChange":"Fusions","cancerType":"All Solid Tumors","level":"3A","drugs":"Larotrectinib, Entrectinib","pmids":"26216294, 29466156, 28183697","abstracts":"Pishvaian et al. Abstract# 521, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155954/abstract"},{"isoform":"ENST00000263967","refSeq":"NM_006218.2","entrezGeneId":5290,"gene":"PIK3CA","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Breast Cancer","level":"3A","drugs":"Buparlisib, Alpelisib + Fulvestrant, Serabelisib, Copanlisib, GDC-0077, Taselisib + Fulvestrant, Alpelisib, Buparlisib + Fulvestrant, Taselisib","pmids":"25877889, 22049316, 29401002, 28490463, 24652201, 24608574, 23662903, 22188813, 27672108, 25172762","abstracts":"Staben et al. Abstract# DDT02-01, AACR 2017 http://www.abstractsonline.com/pp8/#!/4292/presentation/11034; Di Leo et al. Abstract# S4-07, SABCS 2016 http://cancerres.aacrjournals.org/content/77/4_Supplement/S4-07; Dickler et al. Abstract# 520, ASCO 2016 http://meetinglibrary.asco.org/content/165518-176; Wade et al. Abstract# 9054, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.9054; Juric et al. Abstract# 334, MBCC 2016 http://www.onclive.com/conference-coverage/mbcc-2016/alpelisib-combo-promising-in-pik3ca-altered-heavily-pretreated-breast-cancer; Edgar et al. Abstract# 156, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/156"},{"isoform":"ENST00000331920","refSeq":"NM_000264.3","entrezGeneId":5727,"gene":"PTCH1","variant":"Truncating Mutations","proteinChange":"Truncating Mutations","cancerType":"Embryonal Tumor","level":"3A","drugs":"Sonidegib","pmids":"24900187, 24523439","abstracts":""},{"isoform":"ENST00000331920","refSeq":"NM_000264.3","entrezGeneId":5727,"gene":"PTCH1","variant":"Truncating Mutations","proteinChange":"Truncating Mutations","cancerType":"Skin Cancer, Non-Melanoma","level":"3A","drugs":"Sonidegib, Vismodegib","pmids":"29320312, 24900187, 22670903, 22670904, 24523439","abstracts":""},{"isoform":"ENST00000355710","refSeq":"NM_020975.4","entrezGeneId":5979,"gene":"RET","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"Medullary Thyroid Cancer","level":"3A","drugs":"LOXO-292","pmids":"29912274","abstracts":"Drilon et al. Abstract# 102, ASCO 2018 https://meetinglibrary.asco.org/record/161573/abstract"},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"C1156Y","proteinChange":"C1156Y","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"Lorlatinib","pmids":"26698910, 29650534","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"G1269A","proteinChange":"G1269A","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"Lorlatinib","pmids":"29650534","abstracts":"Besse et al. Abstract #9032, ASCO 2018 https://media4.asco.org/214/12951/160995/160995_poster_big_1.jpg"},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"I1171N","proteinChange":"I1171N","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"Lorlatinib","pmids":"29650534","abstracts":"Besse et al. Abstract #9032, ASCO 2018 https://media4.asco.org/214/12951/160995/160995_poster_big_1.jpg"},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"L1196M","proteinChange":"L1196M","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"Lorlatinib","pmids":"29650534, 29074098","abstracts":"Besse et al. Abstract #9032, ASCO 2018 https://media4.asco.org/214/12951/160995/160995_poster_big_1.jpg"},{"isoform":"ENST00000278616","refSeq":"NM_000051.3","entrezGeneId":472,"gene":"ATM","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Solid Tumors","level":"4","drugs":"Olaparib","pmids":"26510020","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D287H","proteinChange":"D287H","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594","proteinChange":"D594","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"F595L","proteinChange":"F595L","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G464","proteinChange":"G464","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G466","proteinChange":"G466","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G469","proteinChange":"G469","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G596","proteinChange":"G596","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"K601","proteinChange":"K601","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597","proteinChange":"L597","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"N581","proteinChange":"N581","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"S467L","proteinChange":"S467L","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V459L","proteinChange":"V459L","cancerType":"All Tumors","level":"4","drugs":"PLX8394","pmids":"26466569, 28659148, 28783719","abstracts":""},{"isoform":"ENST00000304494","refSeq":"NM_000077.4","entrezGeneId":1029,"gene":"CDKN2A","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Solid Tumors","level":"4","drugs":"Abemaciclib, Palbociclib, Ribociclib","pmids":"19874578, 25941111, 24495407, 29232554, 28283584","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"A289V","proteinChange":"A289V","cancerType":"Glioma","level":"4","drugs":"Lapatinib","pmids":"18334972, 20459769, 22588883","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Amplification","proteinChange":"Amplification","cancerType":"Glioma","level":"4","drugs":"Lapatinib","pmids":"18334972, 20459769, 22588883","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"R108K","proteinChange":"R108K","cancerType":"Glioma","level":"4","drugs":"Lapatinib","pmids":"18334972, 20459769, 22588883","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"T263P","proteinChange":"T263P","cancerType":"Glioma","level":"4","drugs":"Lapatinib","pmids":"18334972, 20459769, 22588883","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"D761Y","proteinChange":"D761Y","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"Osimertinib","pmids":"28424065, 17085664","abstracts":""},{"isoform":"ENST00000397938","refSeq":"NM_005243.3","entrezGeneId":2130,"gene":"EWSR1","variant":"EWSR1-FLI1 Fusion","proteinChange":"EWSR1-FLI1 Fusion","cancerType":"Ewing Sarcoma","level":"4","drugs":"TK216","pmids":"19584866","abstracts":"Selvanathan et al. Abstract# 694, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/694"},{"isoform":"ENST00000425967","refSeq":"NM_001174067.1","entrezGeneId":2260,"gene":"FGFR1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Solid Tumors","level":"4","drugs":"AZD4547, Erdafitinib, BGJ398, Debio1347","pmids":"26438159, 25169980, 27870574, 23082000","abstracts":"Voss, MH et al. Abstract# 2500, ASCO 2017 http://meetinglibrary.asco.org/record/144575/abstract; Brichory F et al. Abstract# 2088, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/2088"},{"isoform":"ENST00000358487","refSeq":"NM_000141.4","entrezGeneId":2263,"gene":"FGFR2","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Solid Tumors","level":"4","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"26438159, 25169980, 27870574, 23082000","abstracts":"Voss, MH et al. Abstract# 2500, ASCO 2017 http://meetinglibrary.asco.org/record/144575/abstract; Brichory F et al. Abstract# 2088, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/2088"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Solid Tumors","level":"4","drugs":"AZD4547, BGJ398, Erdafitinib, Debio1347","pmids":"26438159, 21119661, 29848605, 26324363, 25169980, 27870574, 23082000","abstracts":"Voss, MH et al. Abstract# 2500, ASCO 2017 http://meetinglibrary.asco.org/record/144575/abstract; Siefker-Radtke et al. Abstract#4503, ASCO 2018 https://meetinglibrary.asco.org/record/160559/abstract; Brichory F et al. Abstract# 2088, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/2088"},{"isoform":"ENST00000256078","refSeq":"NM_033360.2","entrezGeneId":3845,"gene":"KRAS","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"Cobimetinib, Binimetinib, Trametinib","pmids":"29247021, 28783719","abstracts":"Robarge et al. Abstract# DDT02-03, AACR 2014 http://cancerres.aacrjournals.org/content/74/19_Supplement/DDT02-03; Bhagwat et al. Abstract# 4973, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/4973; Burrows et al. Abstract# 5168, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/5168"},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Solid Tumors","level":"4","drugs":"Temsirolimus, Everolimus","pmids":"24631838, 27482884, 26831717, 24622468","abstracts":""},{"isoform":"ENST00000358273","refSeq":"NM_001042492.2","entrezGeneId":4763,"gene":"NF1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Solid Tumors","level":"4","drugs":"Cobimetinib, Trametinib","pmids":"24576830, 26936308, 24535670","abstracts":""},{"isoform":"ENST00000371953","refSeq":"NM_000314.4","entrezGeneId":5728,"gene":"PTEN","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"GSK2636771, AZD8186","pmids":"28645941","abstracts":"Hansen et al. Abstract# 2570, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2570"},{"isoform":"ENST00000263121","refSeq":"NM_003073.3","entrezGeneId":6598,"gene":"SMARCB1","variant":"Oncogenic Mutations","proteinChange":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"Tazemetostat","pmids":"29650362, 23620515, 20951942, 27391784","abstracts":"Chi et al. Abstract# A175, AACR-NCI-EORTC 2017 http://www.abstractsonline.com/pp8/#!/4557/presentation/616"},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"C1156Y","proteinChange":"C1156Y","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Crizotinib","pmids":"22235099, 23434628, 27045755, 26144315, 20979473, 26698910, 24675041","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"G1202R","proteinChange":"G1202R","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Alectinib","pmids":"29376144, 29650534, 27130468, 27432227, 24736079, 29373100","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"G1269A","proteinChange":"G1269A","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Crizotinib","pmids":"28434515, 22235099, 23434628, 27045755, 23344087, 24675041","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"I1171N","proteinChange":"I1171N","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Alectinib","pmids":"29376144, 23239810, 29650534, 25393798, 25393796, 27565911, 25736571","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"L1196M","proteinChange":"L1196M","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Crizotinib","pmids":"28434515, 22235099, 23434628, 22277784, 23344087, 27432227, 24675041","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"C797G","proteinChange":"C797G","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Osimertinib","pmids":"29713646, 27086175","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"C797S","proteinChange":"C797S","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Osimertinib","pmids":"26749488, 28625641, 26181354, 25939061","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"D761Y","proteinChange":"D761Y","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Gefitinib","pmids":"28424065, 17085664, 17192902, 22052230","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","proteinChange":"C788_N828mut","cancerType":"Gastrointestinal Stromal Tumor","level":"R2","drugs":"Imatinib, Sunitinib","pmids":"22301675, 23840364, 25239608, 18955458","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"T670I","proteinChange":"T670I","cancerType":"Gastrointestinal Stromal Tumor","level":"R2","drugs":"Imatinib","pmids":"16551858, 17545544, 23840364, 1675110, 16954519, 17699867","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"V654A","proteinChange":"V654A","cancerType":"Gastrointestinal Stromal Tumor","level":"R2","drugs":"Imatinib","pmids":"23840364, 18955458","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Amplification","proteinChange":"Amplification","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Erlotinib, Gefitinib","pmids":"18093943, 17463250","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1228N","proteinChange":"D1228N","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Crizotinib, Cabozantinib, Capmatinib","pmids":"28396313, 27987579, 28522754, 27343442, 29128427","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1230H","proteinChange":"Y1230H","cancerType":"Non-Small Cell Lung Cancer","level":"R2","drugs":"Crizotinib","pmids":"27666659, 28396313, 27987579, 28522754, 29128427","abstracts":""}]